Matches in Wikidata for { <http://www.wikidata.org/entity/Q37045536> ?p ?o ?g. }
- Q37045536 description "article científic" @default.
- Q37045536 description "article scientifique" @default.
- Q37045536 description "articolo scientifico" @default.
- Q37045536 description "artigo científico" @default.
- Q37045536 description "artículu científicu espublizáu en 2016" @default.
- Q37045536 description "bilimsel makale" @default.
- Q37045536 description "scientific article published on 14 March 2016" @default.
- Q37045536 description "vedecký článok" @default.
- Q37045536 description "vetenskaplig artikel" @default.
- Q37045536 description "videnskabelig artikel" @default.
- Q37045536 description "vědecký článek" @default.
- Q37045536 description "wetenschappelijk artikel" @default.
- Q37045536 description "wissenschaftlicher Artikel" @default.
- Q37045536 description "наукова стаття, опублікована в березні 2016" @default.
- Q37045536 description "научни чланак" @default.
- Q37045536 description "مقالة علمية نشرت في 14 مارس 2016" @default.
- Q37045536 name "90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years" @default.
- Q37045536 name "90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years" @default.
- Q37045536 name "90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years" @default.
- Q37045536 type Item @default.
- Q37045536 label "90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years" @default.
- Q37045536 label "90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years" @default.
- Q37045536 label "90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years" @default.
- Q37045536 prefLabel "90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years" @default.
- Q37045536 prefLabel "90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years" @default.
- Q37045536 prefLabel "90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years" @default.
- Q37045536 P1433 Q37045536-AF93DFE2-E48A-4FF8-AD37-F31825DE2AD8 @default.
- Q37045536 P1476 Q37045536-E286B3FC-1736-4F56-B897-A4651E881E69 @default.
- Q37045536 P2093 Q37045536-24FC4111-2A69-4FDB-80A4-4F032FBB907E @default.
- Q37045536 P2093 Q37045536-29A81DDF-42C2-4269-A1B0-63D232760847 @default.
- Q37045536 P2093 Q37045536-4B54CCEF-F9BC-4252-9A69-4BBFF5F3556A @default.
- Q37045536 P2093 Q37045536-7A090261-ED8F-4A94-9CC9-F66C8F630796 @default.
- Q37045536 P2093 Q37045536-87E0E7C9-E748-4B40-8D0F-B851E50FC52E @default.
- Q37045536 P2093 Q37045536-D58B9532-3CC2-4E7F-A565-C39AFDF57F96 @default.
- Q37045536 P2860 Q37045536-0645CE43-C2D4-4E81-A750-AE19A31E871C @default.
- Q37045536 P2860 Q37045536-0DDC23F8-1F78-43B3-913A-BB8D3F79BEAC @default.
- Q37045536 P2860 Q37045536-1202F9C9-F434-4F0A-AF65-F1F7C9B91964 @default.
- Q37045536 P2860 Q37045536-2BEF7D62-7416-4210-AD4A-89D8C7813B8C @default.
- Q37045536 P2860 Q37045536-3FE5231E-ECFE-43AC-8025-12075E5D6FDF @default.
- Q37045536 P2860 Q37045536-41F070E3-E26F-4B60-9D24-6D48054D068E @default.
- Q37045536 P2860 Q37045536-4652A363-2F9E-4509-93F4-A12F6D394E36 @default.
- Q37045536 P2860 Q37045536-52AC965E-A6D6-42BE-B773-3A0CE805FDE1 @default.
- Q37045536 P2860 Q37045536-5661A364-54FA-4CAC-8C00-E0FF26E6FE2E @default.
- Q37045536 P2860 Q37045536-5C66111B-1FD2-4F13-86CE-E47C260C82A5 @default.
- Q37045536 P2860 Q37045536-5CE56AF9-9A15-4D9E-A9E6-4A17B910B6F1 @default.
- Q37045536 P2860 Q37045536-61280876-2D4A-4B95-B709-DD36928964EE @default.
- Q37045536 P2860 Q37045536-69DB11A0-D561-48F1-A5DD-CB755FA1BD0A @default.
- Q37045536 P2860 Q37045536-7BBF4FEF-DEAB-4AEF-8024-E5DA4CCBD9F1 @default.
- Q37045536 P2860 Q37045536-93687FEB-BD70-4EC1-AB9C-169D042EB236 @default.
- Q37045536 P2860 Q37045536-963EEC75-1B18-4795-9D97-4C5F902A1EC0 @default.
- Q37045536 P2860 Q37045536-A2BB2D39-0650-477B-B836-CDE6F46387D6 @default.
- Q37045536 P2860 Q37045536-A7AD9195-9597-4805-8425-D1EAF13468D5 @default.
- Q37045536 P2860 Q37045536-C4FB24A8-F103-44B4-96BA-2AB55C72C723 @default.
- Q37045536 P2860 Q37045536-D66ECE1A-B173-4B8A-9244-3DC6872B7E2F @default.
- Q37045536 P2860 Q37045536-E91EA905-1017-4E22-BAC9-D11E6F7EA32C @default.
- Q37045536 P2860 Q37045536-EC17C5D2-6C9A-4A1B-BD93-28F8A46D3249 @default.
- Q37045536 P2860 Q37045536-F3909D5F-F35D-4086-95CE-B3E80EF415A5 @default.
- Q37045536 P2860 Q37045536-F89B6AFB-74D1-46FD-9929-749BE7F21F48 @default.
- Q37045536 P304 Q37045536-6762180D-E3DA-49C3-96A3-4572A13E021C @default.
- Q37045536 P31 Q37045536-40EC1ACA-971B-4D66-BCF2-3BBA56FE08C4 @default.
- Q37045536 P356 Q37045536-D5B2D84E-3DD4-4EC6-B06D-18C08888FFC0 @default.
- Q37045536 P407 Q37045536-67286765-63F8-4C37-ACF0-D30D556F59BB @default.
- Q37045536 P433 Q37045536-8FF2A144-995A-4BAA-80AF-010791BEE4AE @default.
- Q37045536 P478 Q37045536-10FCCAAE-E4A9-413D-9CBF-2CFC6418F2C9 @default.
- Q37045536 P50 Q37045536-195E22CD-C908-4917-BA00-3A958320267F @default.
- Q37045536 P50 Q37045536-3F82BD9A-0102-426A-BB22-E402E75C7A31 @default.
- Q37045536 P50 Q37045536-4BAB720C-E300-4708-ACA7-AB56715F62D5 @default.
- Q37045536 P50 Q37045536-4EB4B716-EBB4-41AE-B8C5-C4426F4BFB2E @default.
- Q37045536 P50 Q37045536-B1F7AB43-BB7D-4998-B47F-6B436E0C33F1 @default.
- Q37045536 P50 Q37045536-B7CF7BBF-29CD-4B3F-B8BF-62519335EA82 @default.
- Q37045536 P50 Q37045536-C0D00371-98E5-4000-8819-C3EB2C8C9C56 @default.
- Q37045536 P577 Q37045536-12E06C33-25F7-4F2E-941D-5A479E86160E @default.
- Q37045536 P698 Q37045536-922C77A5-26A1-4B7D-9B2F-02C39082B851 @default.
- Q37045536 P921 Q37045536-12225DF7-536E-4F7A-ABEF-B8CE22838C34 @default.
- Q37045536 P921 Q37045536-860EB926-17F5-4E60-939B-2A97EF772D28 @default.
- Q37045536 P921 Q37045536-AE0BAA5C-F99E-43FD-8335-31FA94210082 @default.
- Q37045536 P932 Q37045536-1F1DB640-1D55-4C88-B27D-A55DCA163939 @default.
- Q37045536 P356 CAM4.684 @default.
- Q37045536 P698 26990782 @default.
- Q37045536 P1433 Q27724564 @default.
- Q37045536 P1476 "90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years" @default.
- Q37045536 P2093 "Alessandro Broccoli" @default.
- Q37045536 P2093 "Alice Morigi" @default.
- Q37045536 P2093 "Federica Quirini" @default.
- Q37045536 P2093 "Giorgia Annechini" @default.
- Q37045536 P2093 "Letizia Gandolfi" @default.
- Q37045536 P2093 "Lorenzo Tonialini" @default.
- Q37045536 P2860 Q28239256 @default.
- Q37045536 P2860 Q33342594 @default.
- Q37045536 P2860 Q33343445 @default.
- Q37045536 P2860 Q33384992 @default.
- Q37045536 P2860 Q33412158 @default.
- Q37045536 P2860 Q34598460 @default.
- Q37045536 P2860 Q35074729 @default.
- Q37045536 P2860 Q37309631 @default.
- Q37045536 P2860 Q39386942 @default.
- Q37045536 P2860 Q41444373 @default.
- Q37045536 P2860 Q43457873 @default.
- Q37045536 P2860 Q46038765 @default.
- Q37045536 P2860 Q46267048 @default.